BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1554 related articles for article (PubMed ID: 24486481)

  • 1. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
    Terc J; Hansen A; Alston L; Hirota SA
    Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.
    Garg A; Zhao A; Erickson SL; Mukherjee S; Lau AJ; Alston L; Chang TK; Mani S; Hirota SA
    J Pharmacol Exp Ther; 2016 Oct; 359(1):91-101. PubMed ID: 27440420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression.
    Shah YM; Ma X; Morimura K; Kim I; Gonzalez FJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1114-22. PubMed ID: 17170021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells.
    Mencarelli A; Migliorati M; Barbanti M; Cipriani S; Palladino G; Distrutti E; Renga B; Fiorucci S
    Biochem Pharmacol; 2010 Dec; 80(11):1700-7. PubMed ID: 20816942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
    Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
    Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
    World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells.
    Mencarelli A; Renga B; Palladino G; Claudio D; Ricci P; Distrutti E; Barbanti M; Baldelli F; Fiorucci S
    Eur J Pharmacol; 2011 Oct; 668(1-2):317-24. PubMed ID: 21806984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation.
    Cheng J; Shah YM; Ma X; Pang X; Tanaka T; Kodama T; Krausz KW; Gonzalez FJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):32-41. PubMed ID: 20627999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptor 35 contributes to mucosal repair in mice via migration of colonic epithelial cells.
    Tsukahara T; Hamouda N; Utsumi D; Matsumoto K; Amagase K; Kato S
    Pharmacol Res; 2017 Sep; 123():27-39. PubMed ID: 28648739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.
    Grosheva I; Zheng D; Levy M; Polansky O; Lichtenstein A; Golani O; Dori-Bachash M; Moresi C; Shapiro H; Del Mare-Roumani S; Valdes-Mas R; He Y; Karbi H; Chen M; Harmelin A; Straussman R; Yissachar N; Elinav E; Geiger B
    Gastroenterology; 2020 Nov; 159(5):1807-1823. PubMed ID: 32653496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
    Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.
    Salaga M; Bartoszek A; Binienda A; Krajewska JB; Fabisiak A; Mosińska P; Dziedziczak K; Niewinna K; Talar M; Tarasiuk A; Kordek R; Fichna J
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
    Takagi T; Naito Y; Okuda T; Uchiyama K; Adachi S; Mizushima K; Handa O; Kokura S; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1259-65. PubMed ID: 20594253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive androstane receptor regulates the intestinal mucosal response to injury.
    Hudson GM; Flannigan KL; Erickson SL; Vicentini FA; Zamponi A; Hirota CL; Alston L; Altier C; Ghosh S; Rioux KP; Mani S; Chang TK; Hirota SA
    Br J Pharmacol; 2017 Jun; 174(12):1857-1871. PubMed ID: 28320072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epithelium-expressed sialyl Lewis glycans improves colonic mucosal wound healing and protects against colitis.
    Kelm M; Quiros M; Azcutia V; Boerner K; Cummings RD; Nusrat A; Brazil JC; Parkos CA
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function.
    Goggins BJ; Minahan K; Sherwin S; Soh WS; Pryor J; Bruce J; Liu G; Mathe A; Knight D; Horvat JC; Walker MM; Keely S
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G420-G438. PubMed ID: 33470153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.
    Bian Z; Li L; Cui J; Zhang H; Liu Y; Zhang CY; Zen K
    J Pathol; 2011 Dec; 225(4):544-53. PubMed ID: 21590770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Smad5 leads to the disassembly of the apical junctional complex and increased susceptibility to experimental colitis.
    Allaire JM; Darsigny M; Marcoux SS; Roy SA; Schmouth JF; Umans L; Zwijsen A; Boudreau F; Perreault N
    Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G586-97. PubMed ID: 21212325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.